CN103571945B - Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types - Google Patents
Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types Download PDFInfo
- Publication number
- CN103571945B CN103571945B CN201310450028.0A CN201310450028A CN103571945B CN 103571945 B CN103571945 B CN 103571945B CN 201310450028 A CN201310450028 A CN 201310450028A CN 103571945 B CN103571945 B CN 103571945B
- Authority
- CN
- China
- Prior art keywords
- primer
- abl
- probe
- tamra
- fam
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000523 sample Substances 0.000 title claims abstract description 111
- 230000004927 fusion Effects 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 title claims abstract description 21
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 title claims description 16
- 238000012216 screening Methods 0.000 title abstract description 10
- 210000004369 blood Anatomy 0.000 claims abstract description 44
- 239000008280 blood Substances 0.000 claims abstract description 44
- 108010056708 bcr-abl Fusion Proteins Proteins 0.000 claims abstract description 37
- 238000001514 detection method Methods 0.000 claims abstract description 28
- 238000012797 qualification Methods 0.000 claims description 36
- 239000002773 nucleotide Substances 0.000 claims description 30
- 125000003729 nucleotide group Chemical group 0.000 claims description 30
- 238000013461 design Methods 0.000 claims description 15
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000003153 chemical reaction reagent Substances 0.000 claims description 11
- 238000011144 upstream manufacturing Methods 0.000 claims description 11
- 108700025690 abl Genes Proteins 0.000 claims description 9
- 101150049556 Bcr gene Proteins 0.000 claims description 6
- 238000012408 PCR amplification Methods 0.000 claims description 6
- 108700039887 Essential Genes Proteins 0.000 claims description 4
- 230000003321 amplification Effects 0.000 claims description 4
- 239000007850 fluorescent dye Substances 0.000 claims description 4
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 4
- 238000010839 reverse transcription Methods 0.000 claims description 4
- 238000003149 assay kit Methods 0.000 claims description 2
- 238000007499 fusion processing Methods 0.000 claims description 2
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 238000003753 real-time PCR Methods 0.000 abstract description 3
- 238000003752 polymerase chain reaction Methods 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 description 13
- 210000000349 chromosome Anatomy 0.000 description 9
- 239000000047 product Substances 0.000 description 8
- 238000002123 RNA extraction Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 238000011002 quantification Methods 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 5
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 5
- 238000007500 overflow downdraw method Methods 0.000 description 5
- 230000017105 transposition Effects 0.000 description 5
- 238000010200 validation analysis Methods 0.000 description 5
- 208000031261 Acute myeloid leukaemia Diseases 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 3
- 235000017491 Bambusa tulda Nutrition 0.000 description 3
- 241001330002 Bambuseae Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 239000011425 bamboo Substances 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000007403 mPCR Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012544 monitoring process Methods 0.000 description 3
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 description 2
- 208000014697 Acute lymphocytic leukaemia Diseases 0.000 description 2
- 102100026008 Breakpoint cluster region protein Human genes 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 101000933320 Homo sapiens Breakpoint cluster region protein Proteins 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 2
- 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 2
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 230000011278 mitosis Effects 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004441 bcr-abl Fusion Proteins Human genes 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 238000013394 immunophenotyping Methods 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 210000004214 philadelphia chromosome Anatomy 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/143—Multiplexing, i.e. use of multiple primers or probes in a single reaction, usually for simultaneously analyse of multiple analysis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310450028.0A CN103571945B (en) | 2013-09-27 | 2013-09-27 | Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310450028.0A CN103571945B (en) | 2013-09-27 | 2013-09-27 | Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103571945A CN103571945A (en) | 2014-02-12 |
CN103571945B true CN103571945B (en) | 2015-05-06 |
Family
ID=50044653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310450028.0A Active CN103571945B (en) | 2013-09-27 | 2013-09-27 | Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103571945B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106399462A (en) * | 2015-07-27 | 2017-02-15 | 上海睿玻生物科技有限公司 | BCR-ABL fusion gene amplification kit and BCR-ABL fusion gene detection kit |
CN105838792B (en) * | 2016-04-22 | 2019-07-12 | 上海荻硕贝肯生物科技有限公司 | For the primer of qualitative detection leukemia fusion gene, probe, kit and method |
CN107674914A (en) * | 2016-08-02 | 2018-02-09 | 熊术道 | One step single tube standard measure RT PCR detect the expression quantity of chronic myelogenous leukemia BCR ABL1 genes |
CN111808959A (en) * | 2020-07-17 | 2020-10-23 | 杭州艾迪康医学检验中心有限公司 | Primer and method for detecting TCF3-HLF fusion gene |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102533740A (en) * | 2011-09-07 | 2012-07-04 | 杭州艾迪康医学检验中心有限公司 | Reverse transcription-polymerase chain reaction (RT-PCR) primer of human leukemia fusion gene BCR-ABL and application method thereof |
CN102758006A (en) * | 2012-04-25 | 2012-10-31 | 武汉艾迪康医学检验所有限公司 | Kit for detecting relative expression of leukemia BCR/ABL (b3a2, b2a2) fusion gene |
-
2013
- 2013-09-27 CN CN201310450028.0A patent/CN103571945B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102533740A (en) * | 2011-09-07 | 2012-07-04 | 杭州艾迪康医学检验中心有限公司 | Reverse transcription-polymerase chain reaction (RT-PCR) primer of human leukemia fusion gene BCR-ABL and application method thereof |
CN102758006A (en) * | 2012-04-25 | 2012-10-31 | 武汉艾迪康医学检验所有限公司 | Kit for detecting relative expression of leukemia BCR/ABL (b3a2, b2a2) fusion gene |
Non-Patent Citations (1)
Title |
---|
A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts;Thomas Burmeister等;《Leukemia Research》;Elsevier Ltd.;20071024;第32卷;579-585 * |
Also Published As
Publication number | Publication date |
---|---|
CN103571945A (en) | 2014-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102146476B (en) | Fluorescent quantitative PCR kit for detecting alpha-globin gene deletion | |
CN103571945B (en) | Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types | |
JP2022164712A (en) | Method for assessing prognosis or risk of liver cancer by using cpg methylation variation in gene | |
CN109825586A (en) | DNA methylation qPCR kit and application method for lung cancer detection | |
CN105671176A (en) | Probe set and kit for detecting ALK fusion breaking point | |
CN109504780A (en) | DNA methylation qPCR kit and application method for lung cancer detection | |
Yu et al. | DNAzyme based three-way junction assay for antibody-free detection of locus-specific N6-methyladenosine modifications | |
CN105861641A (en) | Primer, kit and method for detecting CHO cell DNA residues | |
CN105969866B (en) | Primer, probe, composition and method for screening and identifying MLL rearrangement related fusion gene by using multiplex fluorescence PCR technology | |
CN109161593B (en) | Application of circular RNA and microRNA in colorectal cancer screening and diagnosis | |
CN103614477A (en) | Fluorescent quantitative PCR (Polymerase Chain Reaction) kit for diagnosing human spinal muscular atrophy | |
CN101955994B (en) | Joint detection method and diagnostic kit of NPM1 (Nucleophosmin 1) gene mutation | |
CN106636441A (en) | Probe for detecting mutation of gene ALDH2, as well as application thereof and kit | |
CN106191311A (en) | A kind of quick detection Cavia porcellus LCMV, SV, PVM, Reo 3 virus multiple liquid phase method for gene chip and reagent | |
CN105648088A (en) | AD or MCI detection marker and detection method thereof | |
CN102212621B (en) | Detection kit and detection method for hepatitis B virus genotyping | |
CN103074438B (en) | Multi-gene detection kit for guiding administration of warfarin and detection method of multi-gene detection kit | |
CN103103287B (en) | Multigene-based influenza C virus real-time fluorescent quantitative RT-PCR (reverse transcription-polymerase chain reaction) detection reagent | |
CN102286625B (en) | Seminal plasma micro RNA combination relevant to male reproductive function disorder and application thereof | |
CN104087672A (en) | Kit for quickly detecting number of human chromosomes 21 by multiplex real-time fluorescence quantitative PCR (polymerase chain reaction) technique | |
Singh et al. | General principles and methods for routine automated microRNA in situ hybridization and double labeling with immunohistochemistry | |
CN103993089A (en) | Vancomycin-resistant enterococcus multiplex fluorescence quantitative PCR (polymerase chain reaction) detection kit and detection method thereof | |
CN106086226A (en) | A kind of blood plasma miRNA mark relevant to IgA nephropathy auxiliary diagnosis and application thereof | |
CN110396542A (en) | A kind of LncRNA marker and its application in diabetes | |
CN107299129A (en) | Circle nucleic acid as breast cancer biomarker application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20140212 Assignee: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. Assignor: SHENYANG ADICON CLINICAL LABORATORIES CO., LTD. Contract record no.: 2015990001017 Denomination of invention: Method, primer, probe and kit for screening and identifying BCR-ABL unusual fusion types Granted publication date: 20150506 License type: Exclusive License Record date: 20151209 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. Assignor: SHENYANG ADICON CLINICAL LABORATORIES CO., LTD. Contract record no.: 2015990001017 Date of cancellation: 20160204 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160219 Address after: 330029, 1111, Qingshan Avenue, hi tech Development Zone, Jiangxi, Nanchang, 1 Patentee after: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. Address before: 110044 No. 252-9, Union Road, Dadong District, Liaoning, Shenyang Patentee before: SHENYANG ADICON CLINICAL LABORATORIES CO., LTD. |
|
C56 | Change in the name or address of the patentee | ||
CP01 | Change in the name or title of a patent holder |
Address after: 330029, 1111, Qingshan Avenue, hi tech Development Zone, Nanchang, Jiangxi, 1, Nanchang Patentee after: Nanchang ADICON Clinical Institute Co Ltd Address before: 330029, 1111, Qingshan Avenue, hi tech Development Zone, Nanchang, Jiangxi, 1, Nanchang Patentee before: Nanchang Adicon ClinIcal Tersting Institute Co., Ltd. |
|
CP03 | Change of name, title or address |
Address after: 330029 Nanchang high tech Development Zone, Jiangxi, Castle Peak Road, No. 1111 Patentee after: Nanchang ADICON clinical laboratories Ltd. Address before: 330029, 1111, Qingshan Avenue, hi tech Development Zone, Nanchang, Jiangxi, 1, Nanchang Patentee before: Nanchang ADICON Clinical Institute Co Ltd |
|
CP03 | Change of name, title or address |